1Mandal M, Mandal A, Das S, et al. Clinical implications of matrix metalloproteinases. Mol Cell Biochem, 2003, 252 ( 1-2 ) :305 -329.
2Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci, 2006, 11(1): 1696-1701.
3Castillo J, Leira R, Blanco M. Metalloproteinases and neurovascular injury. Neurologia, 2004, 19 ( 6 ) : 312 -320.
4Hamacher S, Matern S, Roeb E. Extracellular matrix - from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases. Dtsch Meal Wochenschr, 2004, 129(38): 1976-1980.
5Chakraborti S, Mandal M, Das S, et al. Regulation of matrix metalloproleinases: an overview, Mol Cell Biochem, 2003, 253(1-2) : 269-285.
6Hsieh HL, Yen MH, Jou MJ, et al. Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1. Cell Signal, 2004, 16 ( 10 ) : 1163-1176.
7Chung TW, Lee YC, Kim CH. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J, 2004, 18(10): 1123-1125.
8Ruhul Amin AR, Senga T, Oo ML, et al. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1 beta:a role for the dual signalling pathways, Akt and Erk. Genes Cells,2003, 8(6) : 515-523.
9Kato Y, Lambert CA, Colige AC, et al. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J Biol Chem, 2005, 280 (12):10938-10944.
10Woo JH, Lim JH, Kim YH, et al. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene,2004, 23(10): 1845-1853.
